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Mobilization of intracellular Ca2+ stores regulates a multitude of cellular functions, but 
the role of intracellular Ca2+ release via the ryanodine receptor (RyR) in the brain 
remains incompletely understood. We found that nitric oxide (NO) directly activates 
RyRs, which induce Ca2+ release from intracellular stores of central neurons, and 
thereby promote prolonged Ca2+ signaling in the brain. Reversible S-nitrosylation of 
type 1 RyR (RyR1) triggers this Ca2+ release. NO-induced Ca2+ release (NICR) is 
evoked by type 1 NO synthase-dependent NO production during neural firing, and is 
essential for cerebellar synaptic plasticity. NO production has also been implicated in 
pathological conditions including ischemic brain injury, and our results suggest that 
NICR is involved in NO-induced neuronal cell death. These findings suggest that 
NICR via RyR1 plays a regulatory role in the physiological and pathophysiological 
functions of the brain. 
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Introduction 
Intracellular Ca2+ signaling regulates a myriad of cellular functions (Berridge et al, 2000). In 
addition to Ca2+ influx from extracellular spaces, Ca2+ is mobilized within the cell from 
intracellular Ca2+ stores through two types of Ca2+ release channels: ryanodine receptors 
(RyRs) and inositol 1,4,5-trisphosphate receptors (IP3Rs). The opening of RyRs is regulated 
by Ca2+ channels in the plasma membrane. Whereas the opening of type 2 RyR (RyR2) is 
regulated by an influx of Ca2+ via voltage-gated Ca2+ channels through the Ca2+-induced 
Ca2+ release (CICR) mechanism in cardiac cells, type 1 RyR (RyR1) is physiologically 
regulated by voltage-gated Ca2+ channels through direct protein–protein interactions in 
skeletal muscle cells (Endo, 2009). Although RyR1 is also expressed in the brain, such tight 
Ca2+ channel-mediated regulation of intracellular Ca2+ release via RyR1, as seen in skeletal 
muscle cells, is absent in central neurons (Kano et al, 1995). Therefore, further investigation 
into the regulatory mechanisms and functions of RyR1 in the brain is warranted. 
Nitric oxide (NO) is a ubiquitous intercellular gaseous messenger that is enzymatically 
generated by NO synthase (NOS) (Bredt & Snyder, 1994). In the brain, NO signaling 
regulates many physiological and pathophysiological functions, including synaptic 
plasticity and neuronal cell death. However, the mechanisms by which NO signaling 
regulates neuronal function require further clarification. In vitro single channel 
measurements suggest that NO enhances the probability of RyR1 channel opening through 
S-nitrosylation (Aghdasi et al, 1997; Eu et al, 2000). This mechanism is implicated in Ca2+ 
leak from skeletal muscle Ca2+ stores in pathological conditions (Bellinger et al, 2009; 
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Durham et al, 2008). However, the functional role of NO-dependent effects on RyR1 in the 
brain has not yet been elucidated. 
Therefore, the objective of the present study was to assess if NO has an effect on 
RyR1-mediated Ca2+ signaling in central neurons. Our findings suggest that NO functions 
as a RyR1 agonist to release Ca2+ from neuronal intracellular Ca2+ stores through a 
reversible S-nitrosylation of the RyR1. The resulting Ca2+ signal is required for the 
induction of NO-dependent synaptic plasticity in the cerebellar synapses. NO generation is 
associated with many diseases of the brain. Our results suggest that NO-induced Ca2+ 
release via RyR1 is involved in neuronal cell death. These findings show a novel form of 
Ca2+ signaling in the brain that plays an important part in health and disease. 
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Results 
NO induces Ca2+ release from neuronal intracellular Ca2+ stores 
We examined potential functional interactions between NO and Ca2+ signaling in the 
cerebellar cortex, where NOS1 is highly expressed in granule cells (Bredt et al, 1991). The 
granule cells extend axons to form glutamatergic synapses on the dendrites of Purkinje cells 
(PCs), which abundantly express RyR1 (Furuichi et al, 1994). To our surprise, when an NO 
donor – NOC7 (1-Hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3-methyl-1-triazene) or 
NOR1 ((±)-(E)-4-Methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexenamide) – was 
applied to acute cerebellar slices, the intracellular Ca2+ concentration ([Ca2+]i) increased in 
PC dendrites (Figure 1A and B; Supplementary Figure S1A). The NO-induced Ca2+ increase 
was observed in the absence of extracellular Ca2+ (Figure 1D; Supplementary Figure S1B), 
and was blocked using an inhibitor of the sarco(endo)plasmic reticulum Ca2+ ATPase, 
thapsigargin, which depletes Ca2+ stores (Figure 1B and D). These results suggest that NO 
mediates the release of Ca2+ from neuronal intracellular Ca2+ stores. 
PCs express two types of Ca2+ release channels: RyR and IP3R (Furuichi et al, 1994). 
Of all Ca2+ release channel subtypes, RyR1 and IP3R1 are the most dominant subtypes 
expressed in PCs (Furuichi et al, 1994; Giannini et al, 1995; Mori et al, 2000; Sawada et al, 
2008; Wojcikiewicz, 1995). We examined which of these two channels was responsible for 
the NO-induced [Ca2+]i increase. Application of the IP3R inhibitor heparin at a 
concentration (4 mg ml–1) sufficient to inhibit IP3R in PCs (Takechi et al, 1998) had no 
effect on the [Ca2+]i increase (Figure 1D; Supplementary Figure S1C). Conversely, a RyR 
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inhibitor, dantrolene, blocked the NO-induced [Ca2+]i increase at 36°C (the temperature at 
which the drug’s effects are observed) (Zhao et al, 2001) (Figure 1C and D). Thus, RyR1, 
but not IP3R, seems to be responsible for the NO-induced [Ca2+]i increase. This notion was 
further examined in mice deficient in RyR1 (Takeshima et al, 1994). Because Ryr1–/– mice 
die perinatally, PCs in acute neonatal cerebellar slices were studied. Even though neonatal 
PCs have poor dendritic arborization, intracellular Ca2+ stores in the somata of Ryr1+/+ PCs 
responded to NO to release Ca2+, and this effect was blocked by thapsigargin and dantrolene 
(Figure 1E–G; Supplementary Figure S1D). However, NO did not induce Ca2+ increase in 
Ryr1–/– PCs (Figure 1E–G). The absence of NO-induced Ca2+ responses in Ryr1–/– PCs was 
not due to an impairment of Ca2+ stores, because glutamate-induced Ca2+ release was 
observed in the PCs of the mutant mice (Supplementary Figure S1E). These findings 
indicate that RyR1 underlies the NO-induced [Ca2+]i increase. 
 
NO-induced Ca2+ release in cells expressing exogenous RyR 
We then characterized the agonistic effect of NO on RyR1 using HEK293 cells with 
tetracycline-regulated RyR1 expression (Supplementary Figure S2A and B). In control cells 
without exogenous RyR1 expression, neither NOC7 nor the RyR agonist, caffeine, induced 
a change in [Ca2+]i (Supplementary Figure S2C). Conversely, RyR1-expressing cells 
demonstrated a clear Ca2+ response to both NOC7 (Figure 2A and C) and caffeine (Figure 
2D) in a dose-dependent manner. This NO-induced Ca2+ increase was a reversible process 
(Supplementary Figure S2D), and this effect was completely blocked by thapsigargin or 
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dantrolene (Figure 2A; Supplementary Figure S2E and F). Taken together, these findings 
indicate that RyR1 activation is both necessary and sufficient for NO-induced Ca2+ release 
from intracellular stores. This mechanism will be hereafter referred to as ‘NO-induced Ca2+ 
release’ (NICR).  
There are three subtypes of RyR, all of which are expressed in the brain. We examined 
if subtypes other than RyR1 also function via the NICR mechanism. Cells expressing RyR2 
or RyR3 demonstrated a robust response to caffeine (Supplementary Figure S2G). RyR2 has 
high CICR activity, and cells expressing this subtype generated spontaneous Ca2+ 
oscillations (Supplementary Figure S2G). Despite this, the effect of NO on RyR2 Ca2+ 
release was very slight (Figure 2B; Supplementary Figure S2G). In contrast, cells 
expressing RyR3 responded to NO, although the sensitivity to NO appeared to be lower 
than that of RyR1 (Figure 2B; Supplementary Figure S2G). Thus, NICR occurs 
predominantly via RyR1, to a lesser extent via RyR3, and not via RyR2. 
 
Underlying mechanisms of NO-induced Ca2+ release 
NO exerts its effects via two pathways: activation of soluble guanylyl cyclase (sGC) and 
subsequent cyclic GMP (cGMP) signaling, as well as protein S-nitrosylation (Hess et al, 
2005). It seems unlikely that NICR occurs via the sGC pathway, as its inhibitor 
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) had no inhibitory effects on NICR 
(Figure 2A; Supplementary Figure S2E). We therefore examined the S-nitrosylation 
mechanism. RyR1 has several cysteine residues that are susceptible to S-nitrosylation, and 
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S-nitrosylation particularly at cysteine 3635 enhances the open probability of single RyR1 
channels in planer bilayers (Moore et al, 1999; Sun et al, 2001). To examine the role of 
S-nitrosylation in NICR, we generated HEK293 cells expressing a mutated C3635A-RyR1, 
where the critical cysteine residue was replaced by alanine (Supplementary Figure S2B). 
Caffeine, but not NOC7, led to Ca2+ release in cells expressing C3635A-RyR1 (Figure 2C 
and D). Using the biotin-switch method, we then analyzed S-nitrosylation of RyR1 (Figure 
S2A). RyR1 was transiently S-nitrosylated by NOC7, but S-nitrosylation was significantly 
reduced in C3635A-RyR1 (Figure 2E and F). These results indicate that S-nitrosylation of 
RyR1 is the underlying mechanism of NICR. We also examined whether cerebellar RyR1 is 
S-nitrosylated after NOC7 application, and found that RyR1 S-nitrosylation also occurred in 
cerebellar slice preparations (Supplementary Figure S1F and G).  
There was a marked difference in the time-course of NOC7-induced Ca2+ responses 
between PCs in slice preparations and HEK293 cells. However, the difference can (at least 
in part) be accounted for by the lag time in the increase in NOC7 concentration around the 
neurons, because the NO donor was applied by superfusion of thick slice preparations. In 
accordance with this notion, the time course of NICR in response to 300 µM NOC7 in 
cultured cerebral neurons was similar to that of HEK293 cells (Figure S1H vs. Figure S2G 
top left panel). 
 
NO-induced Ca2+ release is induced by neuronal activity 
Having shown that exogenous NO induces NICR in RyR1-expressing cells, we then studied 
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whether NICR is evoked by endogenous NO signaling in the brain. When physiologically 
relevant burst stimulations (BS; 5 pulses at 50 Hz) (Chadderton et al, 2004) are repeatedly 
applied, parallel fibers (PFs) generate local NO signals near the PF-PC synapses that reach 
micromolar concentrations in acute cerebellar slices (Namiki et al, 2005). Thus, we assessed 
[Ca2+]i in PC dendrites receiving intrinsic NO signaling from PFs. Stimulus intensity was 
adjusted to ensure that glutamatergic Ca2+ responses to a single BS were negligible in 
postsynaptic PC dendrites (Supplementary Figure S3A). A gradual increase in Ca2+ was 
observed in PC dendrites after repetitive application of BS to PFs at 1 Hz for 60 s (Figure 
3A–C), and [Ca2+]i slowly decreased after termination of BS (Figure 3C). The magnitude of 
the BS-induced Ca2+ response was comparable with that of the glutamatergic response 
observed with a high-frequency PF input, but the time course of the BS response was much 
slower (Supplementary Figure S3B vs. C). The BS-induced Ca2+ signal was localized on the 
dendrites near the stimulation electrode (Figure 3A and B), similar to the PF-derived NO 
signal (Namiki et al, 2005). Depletion of Ca2+ stores by thapsigargin abolished the Ca2+ 
increase (Figure 3C and E). Treatment with the IP3R inhibitor heparin via a patch pipette 
had no effect on the BS-induced Ca2+ increase (Figure 3E; Supplementary Figure S3D), 
even though the concentration of heparin (4 mg ml–1) used was sufficient to inhibit 
metabotropic glutamate receptor (mGluR)-mediated, IP3-dependent Ca2+ release in PCs 
(Supplementary Figure S3B). The inhibitory effect of heparin on IP3-dependent Ca2+ release 
was corroborated by another report (Takechi et al, 1998). Conversely, BS-induced Ca2+ 
signaling was blocked by dantrolene (Figure 3D and E). These results indicate that the 
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BS-induced slow [Ca2+]i increase is dependent on Ca2+ release via RyR. Glutamatergic 
signaling is unlikely to be involved, because the BS-induced Ca2+ release was observed in 
the presence of both ionotropic and metabotropic glutamate receptor antagonists, NBQX 
(2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide) and CPCCOEt 
(7-(Hydroxyimino)cyclopropa[b]chromen-1α-carboxylate ethyl ester), respectively (Figure 
3E; Supplementary Figure S3G). We confirmed that these glutamate receptor antagonists 
inhibit glutamatergic Ca2+ responses in PCs (Supplementary Figure S3B). Furthermore, an 
NMDA receptor inhibitor, AP5 (D-(-)-2-amino-5-phosphonopentanoic acid), did not have 
any effect on the BS-induced Ca2+ release (Supplementary Figure S3H). 
We also examined if NO is causally involved in the BS-induced Ca2+ release. We found 
that the NOS inhibitor, L-NAME (NG-Nitro-L-arginine methyl ester), completely blocked 
the BS-induced Ca2+ release (Figure 3E; Supplementary Figure S3I). We also studied 
mutant mice deficient in NOS1 (Huang et al, 1993). The BS-induced NO signal in PCs 
measured using a NO probe (HBR-GFP) (Namiki et al, 2005) was found to be absent in 
Nos1–/– mice, indicating that NOS1 is the dominant source of NO upon PF stimulation 
(Supplementary Figure S3M). Additionally, there was no [Ca2+]i increase in response to BS 
in the PCs of Nos1–/– mice (Figure 3C and E), even though an exogenous NO source, NOC7 
(30 and 300 µM), induced a significant [Ca2+]i increase, which is comparable with that in 
Nos1+/+ mice (Supplementary Figure S3P). Thus, BS-induced Ca2+ release is dependent on 
NOS1-induced NO generation. ODQ (1 and 10 µM) had no inhibitory effects on 
BS-induced Ca2+ release (Figure 3E; Supplementary Figure S3E and F). In addition, 
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ascorbic acid (which has been used for selective reduction of cysteine S-nitrosothiols 
(Burgoyne & Eaton, 2010; Jaffrey et al, 2001)) applied to PCs through the patch pipette 
abolished BS-induced Ca2+ release (Figure S3J). These findings are consistent with the 
involvement of S-nitrosylation, rather than sGC-cGMP signaling, in BS-induced Ca2+ 
release. Furthermore, there were no significant changes in the BS-induced Ca2+ release in 
Ryr3–/– mice (Supplementary Figure S3K). Taken together, these findings indicate that PFs 
stimulated in a physiological manner generate NO, which in turn induces NICR via RyR1 in 
PCs. 
 
Critical role of NICR in cerebellar long-term potentiation 
We next studied the potential physiological or pathophysiological roles of NICR. 
BS-induced NO generation by PFs also induces long-term potentiation (LTP) in the PF-PC 
synapse (Namiki et al, 2005). This form of LTP is similar to PF-LTP, generated by PF 
stimulation at 1 Hz for 5 min (Coesmans et al, 2004; Lev-Ram et al, 2002), in that both are 
generated postsynaptically and are NO-dependent, although they are not cGMP-dependent. 
PF-LTP is dependent upon the level of [Ca2+]i in PC dendrites (Coesmans et al, 2004). 
Confirming that PF stimulation at 1 Hz for 5 min induces LTP (Figure S4K), we measured 
[Ca2+]i in PC dendrites during PF stimulation at 1 Hz. We observed an increase in [Ca2+]i 
with a peak amplitude comparable with that during BS stimulation (Figure S3L). 
Consideration of these previous findings and our findings suggests that NICR may be 
involved in synaptic plasticity, and we tested this possibility.  
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Repeated BS (60 times at 1 Hz) applied to PFs induced a significant potentiation in 
PF-PC synapses that lasted >30 min (Figure 4A). This LTP was absent in Nos1–/– mice 
(Figure 4A and C), although LTP in the Nos1–/– cerebellum could be induced by NOC7 as in 
wild-type animals (Figure S4L). Furthermore, ODQ (10 µM) had no inhibitory effect 
(Supplementary Figure S4G), although 1 µM of ODQ was sufficient to inhibit long-term 
depression (LTD) in the same synapse of the cerebellar slice preparations (Supplementary 
Figure S4M and N), which is known to be dependent upon cGMP signaling (Ito, 2002). 
These results confirm that BS-induced LTP is NO-dependent but not cGMP-dependent. 
Consistent with the central role of NO in LTP induction, mGluR or NMDA receptor 
blockade did not have a significant effect on LTP (Figure 4C; Supplementary Figure S4E 
and F). We then tested if intracellular Ca2+ release has a role in the induction of LTP. Indeed, 
depletion of intracellular Ca2+ stores by thapsigargin abolished LTP (Figure 4C; 
Supplementary Figures S4B and L). Furthermore, dantrolene applied in the bath or 
intracellularly to PCs through a patch pipette blocked LTP (Figure 4B and C; 
Supplementary Figure S4C), whereas intracellular application of heparin to PCs had no 
significant effect (Figure 4C; Supplementary Figure S4D). These findings indicate that Ca2+ 
release via RyR, but not IP3R, is required for the induction of LTP. We also found that the 
S-nitrosylation decomposer ascorbic acid blocked LTP (Figure S4H). Although the 
dominant RyR subtype in PCs is RyR1, RyR3 is also expressed. However, cerebellar LTP 
was similarly induced in slice preparations of Ryr3–/– mice (Supplementary Figure S4I). 
Intracellular application of a Ca2+ buffer, BAPTA (5–30 mM), to PCs through a patch 
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pipette inhibited LTP in a concentration-dependent manner (Figure 4C; Supplementary 
Figure S4J). Although LTP was observed in the presence of 5 mM BAPTA, 10 mM BAPTA 
was sufficient to inhibit LTP. The concentration-dependent effect of BAPTA on LTP 
suggests that local Ca2+ signaling rather than a global increase in the dendritic [Ca2+]i is 
required for LTP induction (see Discussion). Taken together, these findings indicate that 
NICR via the RyR1 in PCs is essential for inducing LTP in PF-PC synapses of the 
cerebellum. 
 
Involvement of NICR in neuronal cell death 
Cerebral ischemia causes NOS-dependent NO generation. NOS1-dependent NO generation 
is implicated in ischemic brain injury, whereas NO generation by type 3 (or endothelial) 
NOS is considered beneficial to brain injury because it increases blood flow (Iadecola, 
1997). Indeed, brain injury after middle cerebral artery occlusion (MCAO) is significantly 
milder in mice treated with a NOS1-specific inhibitor and in Nos1–/– mice (Huang et al, 
1994). The NO concentration reaches micromolar levels in ischemic cerebral tissue during 
and after MCAO (Malinski et al, 1993). Such NO signaling during ischemia is expected to 
activate NICR in neurons. We therefore examined whether or not NICR is involved in 
NOS1-dependent brain injury. 
We first used a mouse MCAO model to examine the potential role of NICR in ischemic 
brain injury. In line with another study (Huang et al, 1994), ischemic brain injury in the 
MCAO model was milder in Nos1–/– mice than in Nos1+/+ mice (Figure 5A and B). We then 
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examined the effects of the NICR inhibitor dantrolene, and found that subarachnoidal 
administration of dantrolene after reperfusion of MCAO had a protective effect on 
MCAO-induced brain injury in Nos1+/+ mice (Figure 5A and B). These findings are 
corroborated by similar findings in other animal models (Li et al, 2005). Conversely, there 
was very little effect of dantrolene on infarction volume in Nos1–/– mice (Figure 5B). These 
results suggest that NOS1-dependent NICR may play a role in ischemic brain injury 
following reperfusion in the MCAO model. 
We next analyzed the potential role of NICR in NO-induced neuronal cell death in 
culture. NOC12 (a sister NO donor with a longer half-life than NOC7) was used to mimic a 
prolonged increase in NO concentrations during brain ischemia (Malinski et al, 1993) (see 
Supplementary materials and methods). NOC12 induced an increase in [Ca2+]i in cerebral 
neurons of wild-type mice (Figure 6A Left). The [Ca2+]i increase was observed in the 
absence of extracellular Ca2+, and was abolished in the presence of dantrolene (Figure 6B) 
or in cerebral neurons from Ryr1–/– mice (Figure 6A Right). We thus confirmed the presence 
of NICR in cerebral neurons. When we examined neuronal cell death after application of 
NOC12, there was a significant increase in cerebral neuron death 16 h after the NO donor 
treatment (Figure 6C and D). However, in the presence of dantrolene, NO donor-induced 
neuronal cell death was significantly attenuated (Figure 6C and D). These results suggest 
that NICR is (at least in part) involved in NO-induced neuronal cell death. Dantrolene may 
have effects other than NICR inhibition, so we further studied the role of NICR in neuronal 
cell death using cerebral neurons obtained from Ryr1–/– mice (Figure 6A Right). Consistent 
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with the notion that NICR is involved in NO-induced cell death, cell death was significantly 
lower in Ryr1–/– neurons compared with Ryr1+/+ neurons (Figure 6C and D). In addition, 
dantrolene had no protective effect on NO donor-induced cell death in Ryr1–/– neurons 
(Figure 6C and D). Taken together, these findings suggest that NICR via RyR1 contributes 
to NO-induced neuronal cell death. 
The potential importance of S-nitrosylation of RyR1 in NO-induced cell death was 
examined in HEK cells expressing extrinsic RyR1. NOC12 application induced a 
dose-dependent increase in [Ca2+]i in cells expressing RyR1, but not in cells expressing 
C3635A-RyR1 (Figure S5A), as in the case of NOC7 (Figure 2C). The NOC12-induced 
Ca2+ increase was abolished by 10 µM ryanodine (Figure S5B). We then analyzed the effect 
of NOC12 on cell viability using the MTT assay 16 h after the NO donor treatment. NOC12 
induced dose-dependent suppression of cell viability in cells expressing wild-type RyR1 
(Figure S5C). Although the same effect of anisomycin on cell viability was observed in cells 
expressing RyR1 or C3635A-RyR1, the effect of NOC12 was significantly attenuated in 
cells expressing C3635A-RyR1 at 2 mM and 3 mM NOC12, but not at 1 mM NOC12, 
where Ca2+ release was not observed (Figure S5C). Furthermore, dantrolene, which blocks 
NOC12-induced Ca2+ increase (Figure S6B), showed a protective effect against 3 mM 
NOC12-induced cell viability loss in cells expressing wild-type RyR1, but not in cells 
expressing C3635A-RyR1 (Figure S6C). These results support the notion that 




In the present study, it was found that NO induces Ca2+ release via RyR1 in central 
neurons. The agonistic effect of NO on intracellular Ca2+ release is mediated by 
S-nitrosylation of RyR1, in particular at cysteine 3635 of the Ca2+ release channel in an 
extrinsic expression system. The same mechanism may underlie the NO-induced Ca2+ 
responses in neurons, although confirmation is required. The modulation of Ca2+ release via 
S-nitrosylation of RyR1 has been implicated in skeletal muscle contractions in low PO2 and 
pathological conditions (Bellinger et al, 2009; Durham et al, 2008; Eu et al, 2003). Thus, 
although RyR1 is primarily regulated by voltage-gated Ca2+ channels through direct 
protein–protein interactions in skeletal muscle cells, NO-induced S-nitrosylation of RyR1 
has a modulatory, enhancing effect on Ca2+ release in these cells. However, the tight 
regulation of RyR1 via Ca2+ channels, as seen in skeletal muscle cells, has not yet been 
demonstrated in central neurons (Kano et al, 1995). In contrast to the rapid and transient 
RyR1-mediated Ca2+ release events as seen during twitch and tetanus contractions in 
skeletal muscle, NICR induced by synaptic input in central neurons produces a much slower 
and prolonged increase in [Ca2+]i. It remains to be elucidated if NO has a similar direct 
Ca2+-releasing effect via RyR1 outside the brain, where the time-course of NICR can be 
influenced by many factors. These include the expression levels of RyR1 and SERCA, the 
time-course of NO increase, and the rate of removal of S-nitrosylation. 
Other subtypes of RyR, RyR2 and RyR3 are also expressed in the brain. It was found 
that RyR3 also mediates NICR. RyR1 is the most dominant RyR subtype found in cerebellar 
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PCs (Furuichi et al, 1994; Giannini et al, 1995; Mori et al, 2000; Sawada et al, 2008), and it 
is likely that this subtype mediates NICR and LTP in these cells. Supporting this notion, 
PCs of Ryr3–/– mice demonstrated BS-induced NICR and LTP, whose levels were 
comparable with that of wild-type mice (Supplementary Figure S3K and S4I). Despite this, 
it remains to be examined whether NICR via RyR3 has physiological and 
pathophysiological roles in other regions of the brain. 
Unlike RyR1 in skeletal muscle, RyR2 is regulated by the CICR mechanism in cardiac 
muscle. Corroborating the results of another report (Sun et al, 2008), there was virtually no 
direct effect of NO on Ca2+ release via RyR2 (Figure 2B). Given that the important cysteine 
residue (i.e. cysteine 3635 of RyR1) is conserved among all RyR subtypes (Supplementary 
Figure S2H), subtype specificity in NICR is remarkable. Thus, the three-dimensional 
structure around the critical cysteine residue may be important for S-nitrosylation or channel 
gating. However, this mechanism requires further clarification. Interestingly, RyR2 can be 
activated by S-nitrosoglutathione, which can also be formed in the brain (Kluge et al, 1997; 
Sun et al, 2008). Dantrolene, which does not block RyR2 (Zhao et al, 2001), abolished 
NICR and LTP in PCs, so S-nitrosoglutathione-mediated RyR2 activation is not likely to 
play a major part in the neuronal functions explored in the present study. 
NICR is induced by mimicking physiological patterns of neuronal activity, and is 
essential in inducing cerebellar LTP, which is the reverse process of cerebellar LTD 
(Coesmans et al, 2004; Lev-Ram et al, 2003). Cerebellar LTP has also been implicated in 
the memory of fear (Sacchetti et al, 2004). As to the molecular mechanism of LTP, 
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N-ethylmaleimide-sensitive factor (NSF)-dependent recruitment of AMPAR in the 
postsynaptic membrane has been shown to underlie cerebellar LTP (Kakegawa & Yuzaki, 
2005). Furthermore, S-nitrosylation of NSF promotes the surface expression of AMPA 
receptors in central neurons (Huang et al, 2005). These previous results indicate that NSF is 
an important target of NO in cerebellar LTP induction. Cerebellar LTP depends not only on 
NO but also on the level of [Ca2+]i in PCs (Coesmans et al, 2004). However, the relationship 
between these signals is incompletely understood. NICR is a plausible candidate that links 
NO and [Ca2+]i. In general agreement with this notion, intracellular application of BAPTA 
(5–30 mM) to PCs had a dose-dependent inhibitory effect on LTP (Figure S4J). Interestingly, 
5 mM BAPTA was not sufficient to inhibit LTP, in line with the successful generation of 1 
Hz-LTP in the presence of 5 mM BAPTA (Lev-Ram et al, 1995). The absence of an 
inhibitory effect of 5 mM BAPTA on LTP may be partly explained by prevention of residual 
LTD (Lev-Ram et al, 1995). Because 5 mM BAPTA is expected to inhibit a global increase 
in the dendritic [Ca2+]i, the result may also suggest involvement of local Ca2+ signaling in 
the generation of LTP. Single-channel openings of RyR1 and RyR2 generate ionic currents 
of ~0.5 pA under near-physiological ionic conditions (Kettlun et al, 2003). These unitary 
events would generate a localized increase in Ca2+ concentration around the RyR. A recent 
study showed that the Ca2+ binding rate constants of calmodulin are so high that calmodulin 
can effectively “trap” Ca2+ immediately when Ca2+ enters the cytoplasm before it binds to 
cytoplasmic Ca2+ buffers (Faas et al, 2011). Therefore, if calmodulin or other Ca2+-binding 
proteins with similar Ca2+-binding properties are involved in the signaling process 
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downstream of the Ca2+ release from the RyR, it is possible that lower concentrations of 
BAPTA cannot completely block the process. An example can be found in cardiac cells, in 
which RyR2 and L-type Ca2+ channels localize closely together at the junction between the 
sarcoplasmic reticulum and plasma membrane. L-type Ca2+ channels undergo inactivation 
in response to an increase in [Ca2+]i through a calmodulin-dependent mechanism (Peterson 
et al, 1999; Zühlke et al, 1999). Ca2+ release from RyR2 facilitates the Ca2+-dependent 
inactivation of L-type Ca2+ channels, and the extent of facilitation is suppressed by 
intracellular application of BAPTA (3 and 10 mM) in a concentration-dependent manner. 
However, a considerable fraction of Ca2+ release-dependent inactivation remains even in the 
presence of BAPTA: about 61% and 32% of control with 3 and 10 mM BAPTA, 
respectively, at –20 mV (Sham, 1997). Under this experimental condition, RyR2 is activated 
by Ca2+ influx through L-type Ca2+ channels, so BAPTA also inhibits the activation of RyR2 
itself. Therefore, the inhibitory effect of BAPTA on Ca2+ release-induced L-type Ca2+ 
channel inactivation per se is overestimated. These considerations suggest that close 
localization of RyR1 and downstream signal transduction molecules may be involved in the 
generation of LTP. Of course, this mechanism requires further clarification. Taken together, 
RyR1 is very likely to be another essential target of NO in cerebellar LTP induction. NOS1 
and RyR1 are co-expressed in various regions of the brain, so NICR may have additional 
physiological roles in the brain. 
NO is implicated in various pathological conditions, including ischemic brain injury, 
via the generation of reactive nitrogen species such as peroxynitrite (Pacher et al, 2007). 
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Our results suggest that NICR via RyR1 is also involved in NO-induced cell death in 
cerebral neurons in culture. The NO-induced neuronal cell death was significantly milder in 
RyR1–/– neurons, in which NICR was absent. In addition, the NO-induced neuronal cell 
death was attenuated by dantrolene (which inhibits NICR), and the protective effect of 
dantrolene was absent in Ryr1–/– neurons. Dantrolene also had a protective effect on 
ischemic brain injury in the MCAO model. Taken together, these findings suggest that 
NOS1-dependent NO generation may exert its adverse effects in ischemic neuronal cell 
death, in part, via NICR, causing either an excessive increase in neuronal Ca2+ 
concentrations or depleting intracellular Ca2+ stores, which in turn stresses the endoplasmic 
reticulum (Li et al, 2005). We studied the importance of cysteine 3635 of RyR1 in cell 
viability in HEK-293 cells. The results suggested that the cysteine residue is one of the 
important factors in NO-induced cell death. To corroborate the notion of the involvement of 
NICR in ischemic neuronal cell death, we tried to measure S-nitrosylation levels of RyR1 in 
the cerebral cortex. Thus far, the measurement has been difficult because the level of protein 
expression of RyR1 in the mouse cerebral cortex is not sufficiently high for reliable 
determination with the biotin switch method. A new detection method with a higher 
sensitivity is needed, and this issue should be addressed in future studies. Ischemic brain 
injury is a complex process, and the roles of NICR in the disease process require further 
clarification. With this reservation, it seems possible that drugs that inhibit NICR may have 
therapeutic value in some forms of ischemic brain injury. 
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Materials and methods 
 
Experiments using animals 
All animal-related procedures were in accordance with the guidelines of The University of 
Tokyo (Tokyo, Japan). 
 
Slice preparation and whole-cell patch-clamp recording 
C57BL/6 mice (postnatal days 24–32) were sacrificed by cervical dislocation under 
anesthesia with diethyl ether. The cerebellum was excised, and parasagittal cerebellar slices 
(250-µm thick) prepared from the vermis (Edwards et al, 1989; Kakizawa et al, 2005; 
Kakizawa et al, 2000). Nos1–/– and Nos1+/– mice (Huang et al, 1993) were obtained from 
The Jackson Laboratory. In experiments using Ryr1–/– mice, cerebellar slices were prepared 
from neonatal animals because of the neonatal lethality of these mice (Takeshima et al, 
1994). Ryr3–/– mice were also used (Takeshima et al, 1996). Whole-cell recordings were 
obtained from visually identified PCs under an upright microscope (BX51WI, Olympus, 
Tokyo, Japan) using a 40× water-immersion objective at room temperature (23–25°C), with 
the exception of experiments that used dantrolene (36 ± 1°C). The resistance of the patch 
pipettes was 2.0–3.5 MΩ when filled with an intracellular solution (in mM) composed of: 
130 K-gluconate, 10 KCl, 10 NaCl, 1 EGTA, 4 ATP-Mg, 0.4 GTP-Na and 10 HEPES (pH 
7.3; adjusted with KOH). The standard bathing solution (in mM) was composed of: 125 
NaCl, 2.5 KCl, 2 CaCl2, 1 MgSO4, 1.25 NaH2PO4, 26 NaHCO3, and 20 glucose, bubbled 
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with 95% CO2 and 5% CO2. Bicuculline (10 µM) was always added to block the inhibitory 
postsynaptic currents. 
 
Ca2+ imaging in slice preparations 
For intracellular Ca2+ imaging in PCs, a Ca2+-sensitive dye, Oregon Green 488 BAPTA-1 
(100 µM), was introduced into PCs through the patch pipette, and the concentration of 
EGTA in the pipette solution was decreased to 0.5 mM. Five-to-nine sequential confocal 
images (excitation at 488 nm), obtained at 3–4 µm z-axis intervals, were acquired every 0.8 
s using an upright microscope (BX51WI; Olympus) equipped with a confocal scanning unit 
and an argon laser (FV300, Olympus), and projected onto a plane to obtain dendrite images 
at 10-s or 5-s intervals. 
 
Electrophysiological measurements 
For focal stimulation of PFs, a stimulation pipette (tip diameter, 5–10 µm) was filled with 
standard bathing solution and used to apply square pulses (0.1 ms in duration, 0–20 V in 
amplitude) to the molecular layer, specifically in the middle portion of the molecular layer 
approximately one-third of the distance below the pial surface. The intensity of each 
stimulus was adjusted to evoke PF-EPSCs with an amplitude of 60–120 pA. The ionic 
current was recorded from PCs using a patch-clamp amplifier (EPC-9, HEKA, 
Lambrecht/Pfalz, Germany) at a holding potential of –90 or –80 mV, after compensating for 
the liquid junction potential. The signals were filtered at 2 kHz and digitized at 20 kHz. 
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Expression of exogenous RyR1, RyR2 and RyR3 in HEK293 cells 
Full-length RyR1 cDNA (Takeshima et al, 1989) was subcloned into the multiple cloning 
sites (MCS) of the pcDNA/FRT/TO expression vector (Invitrogen, Carlsbad, CA, USA) that 
was modified by the addition of a Nhe I site. Tetracycline-inducible stable HEK293 cell 
lines were generated using the Flp-In T-REx system according to manufacturer’s 
instructions. RyR2 cDNA (Nakai et al, 1990) was similarly subcloned into the 
pcDNA/FRT/TO vector, and stable HEK293 cell lines obtained (Chugun et al, 2007). RyR3 
cDNA (Chen et al, 1997) (a kind gift from Dr. SR Chen, University of Calgary, Alberta, 
Canada) was similarly expressed in HEK293 cells. Flp-In™-293 HEK293 cells were 
cultured on collagen-coated dishes in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% fetal bovine serum, penicillin (100 U/ml), streptomycin (100 U/ml) 
and 2 mM glutamine. HEK293 cells at passages from 10 to 20 were plated onto 
collagen-coated glass-bottom dishes 3 d prior to Ca2+ imaging. The generation of 
C3635A-RyR1 is described in Supplementary materials and methods. 
 
Cerebral neuron culture 
Neurons were prepared from the cerebral cortices of wild-type or Ryr1–/– mice fetuses 
[embryonic day 16 (E16) or E19] based on a modification of a previously described 
procedure (Kanemaru et al, 2007). Briefly, minced cerebral cortices were treated with 2.5% 
trypsin (Invitrogen) and 0.1% DNase I (Sigma–Aldrich, St Louis, MO, USA) in 
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Ca2+/Mg2+-free phosphate-buffered saline (PBS) for 3 min at room temperature. Cells were 
washed with Neurobasal-A medium (Invitrogen) supplemented with 5% fetal calf serum, 
penicillin (100 U/ml), streptomycin (100 U/ml), and 2 mM L-glutamine (Sigma–Aldrich) 
and dissociated by triturating with a fire-polished Pasteur pipette in Ca2+/Mg2+-free PBS 
containing 0.05% DNase I and 0.03% trypsin inhibitor (Sigma–Aldrich). Dispersed cells 
were plated at 5.0–9.0 × 104 cells cm–2 on glass coverslips that had been coated with 
poly-L-lysine (Sigma–Aldrich) and mouse laminin (Invitrogen). Cells were then cultured at 
37°C in Neurobasal-A (Invitrogen) with B-27 supplement (Invitrogen), penicillin (100 
U/ml), streptomycin (100 U/ml), and 2 mM L-glutamine under a humidified atmosphere 
containing 5% CO2. Culture medium contained 5% fetal calf serum for the first day after 
plating. The medium was then changed every 2 d by replacing half of the old medium with 
fresh medium. Cells cultured for 5–20 d were plated onto poly-L-lysine- and laminin-coated 
glass coverslips 7–15 d prior to Ca2+ imaging. Immediately before Ca2+ imaging in cultured 
neurons, CaCl2 in physiological salt solution (PSS) was replaced with equimolar MgCl2 to 
inhibit spontaneous activity. 
 
Ca2+ imaging in cultured cells 
Cells were loaded at room temperature with 4 µM fura-2 AM in PSS (in mM) containing: 
150 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 5.6 glucose and 10 HEPES at pH 7.4. Fluorescence 
images were acquired at >420 nm using an inverted microscope equipped with a cooled 
CCD camera at a rate of one frame every 1 s or 2 s. Excitation wavelengths were 345 nm 
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and 380 nm. Ca2+ imaging experiments were conducted at room temperature, with the 
exception of the experiments conducted with dantrolene (35 ± 1°C). Image analyses were 
carried out using IPLab software (BD Biosciences Bioimaging, Rockville, MD, USA). 
Regions of interest (ROIs) corresponding to individual cells were selected and the mean 
fluorescence intensity (F) of each ROI minus the background intensity was calculated for 
each frame. We used the F345/F380 ratio (the value of F at an excitation wavelength of 345 
nm divided by the value of F at an excitation wavelength of 380 nm) to estimate [Ca2+]i, as 
described elsewhere (Grynkiewicz et al, 1985). The Kd (239 nM) for Ca2+ was determined 
via in vitro calibration of fura-2 fluorescence. 
 
Analyses of NO-induced neuronal cell death 
Primary cultured neurons were exposed to 500 µM NOC12 or vehicle, with or without 10 µM 
dantrolene, and cultured at 37°C. After 16 h, primary cultures were stained with 0.2 µM 
calcein-AM, 1 µM propidium iodide (PI), and 0.4 µM Hoechst 33342 for 10 min at room 
temperature. Fluorescence images were obtained at >420 nm (excitation at 350 nm) for 
Hoechst 33342, 515–550 nm (excitation 480 nm) for calcein, and >600 nm (excitation 540 
nm) for PI using an inverted microscope (IX70; Olympus) equipped with a 40× (N.A. = 0.7) 
or 10× (N.A. = 0. 4) objective and a CCD camera. Cell death was expressed as the number of 
PI-positive cells divided by the number of total cells (Hoechst 33342-positive cells). 




Biotin switch method 
S-nitrosylation of RyR1 in HEK293 cells and in cerebellar slice preparations was detected 
via the biotin switch method (Ckless et al, 2004; Jaffrey & Snyder, 2001). This method 
utilizes a S-nitrosylated protein detection assay kit (Cayman Chemical, Ann Arbor, MI, 
USA) with some modifications, as described in Supplementary materials and methods. 
 
Middle cerebral artery occlusion (MCAO) model 
Male 8–12-week-old Nos1–/– mice and their wild-type littermates weighing 20–30 g at the 
time of surgery were used. Anesthesia was maintained during surgery with 1.5% isoflurane in 
a 30% O2/70% N2O gas mixture. Rectal and occipitocervical muscular temperatures were 
maintained at 37 ± 0.3°C using a heating blanket and lamp. After recovery from anesthesia, 
mice were placed in an incubator at 33°C and 50% humidity to prevent hypothermia, and 
provided with food and water ad libitum. The methodology for generating the MCAO mouse 
model has been described previously (Chen et al, 2008), and is briefly described in the 
Supplementary materials and methods. 
 
Determination of the infarct volume 
After 24 h of reperfusion, mice were deeply anesthetized and intracardially perfused with 
heparinized saline. Brains were extracted and 2-mm coronal sections cut. Individual sections 
were incubated for 20 min in 2% triphenyltetrazolium chloride (TTC) in PBS at 37°C. The 
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TTC was drained and slices placed in 10% formalin for 30 min. Images of the slices were 
acquired using a digital camera. Infarct volume was calculated by two members blinded to the 
study protocol using the Leach correction (Leach et al, 1993):  
 
[Lesion area of each section] = [Ipsilateral lesion area] × ([Contralateral hemisphere area] / 
[Ipsilateral hemisphere area]).  
 
Lesion volume was calculated as the sum of the lesioned areas in all five sections and 
multiplied by slice thickness (2 mm). 
 
Supplementary data 
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Figure 1  NO induces intracellular Ca2+ release via RyR1 in cerebellar Purkinje cells. (A) 
Confocal Ca2+ imaging of Purkinje cell dendrites (left) and pseudocolor Ca2+ imaging of 
cells (right) 120 s following NOC7 (300 µM) treatment. (B) NOC7-induced Ca2+ increase 
with or without thapsigargin (2 µM). (C) NOC7-induced Ca2+ increase at 36°C with or 
without dantrolene (30 µM). (D) Effect of various perturbations (i.e. removal of 
extracellular Ca2+ with 0.5 mM EGTA (0Ca), 2 µM thapsigargin (TG), 4 mg ml–1 heparin 
applied through a patch pipette (Hep), and 30 µM dantrolene (Dan)) on the peak magnitude 
of the NO-induced Ca2+ response. (E) Confocal Ca2+ imaging in the soma of neonatal 
Purkinje cells 120 s after NOC7 (300 µM) treatment in control and Ryr1–/– mice. (F) 
NOC7-induced Ca2+ increase in Purkinje cells treated with or without thapsigargin (2 µM) 
and in Ryr1–/– Purkinje cells. (G) Summary of the effect of perturbations on the magnitude 
of NO-induced Ca2+ increase. In all graphs, error bars indicate s.e.m. (n = 5–11). *P < 0.01, 
**P < 0.001, t-test compared with control.  
 
Figure 2  NO-induced Ca2+ release in HEK293 cells expressing RyR1. (A) Effect of 
various perturbations [i.e. without tetracycline induction, control, removal of extracellular 
Ca2+ with 1 mM EGTA (0Ca), 2 µM thapsigargin (TG), 1 µM ODQ, control at 35°C, and 30 
µM dantrolene] on the peak magnitude of NOC7 (300 µM)-induced Ca2+ increase; n = 
50–145. (B) RyR subtype dependence of the NO-induced Ca2+ response. Please refer to 
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Supplementary Figure S2G for more information. (C and D) Ca2+ response to NOC7 and 
caffeine in HEK293 cells expressing RyR1 (left) or C3635A-RyR1 (right); n = 121–245. 
(E) Time-course of NOC7 (1 mM)-induced S-nitrosylation of wild-type and C3635A-RyR1 
cells, as determined by the biotin switch method. (F) Summary of the time-course of 
S-nitrosylation; n = 3–4. In all graphs, error bars indicate s.e.m. *P < 0.02, **P < 0.001, 
t-test compared with control. 
 
Figure 3  Nerve activity induces NICR in Purkinje cells. (A) Confocal Ca2+ imaging of 
Purkinje cell dendrites (left) and pseudocolor Ca2+ imaging of cells (right) 60 s after BS (5 
pulses at 50 Hz repeated 60 times every 1 s). (B) Spatial distribution of BS-induced Ca2+ 
release; n = 5. (C) BS-induced Ca2+ increase in wild-type and Nos1–/– mice with or without 
thapsigargin (2 µM); n = 5–6. (D) BS-induced Ca2+ increase in wild-type mice with or 
without dantrolene (30 µM) at 36°C; n = 5–6. (E) Effect of various perturbations on the 
magnitude of BS-induced Ca2+ increase. Control, thapsigargin, heparin (4 mg ml–1) applied 
through a patch pipette, ODQ (1 µM), cocktail of glutamate receptor antagonists (αGluR: 
20 µM NBQX and 100 µM CPCCOEt), L-NAME (100 µM), Nos1–/–, control at 36°C, and 
dantrolene, n = 5–7. In all graphs, error bars indicate s.e.m. *P < 0.01, **P < 0.001, t-test 
compared with control. 
 
Figure 4  Involvement of NICR in synaptic plasticity. (A) Long-term potentiation (LTP) of 
excitatory postsynaptic currents (EPSCs) at the PF-PC synapse in wild-type and Nos1–/– 
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mice; n = 5. (B) Dantrolene (30 µM) blocked PF-LTP at 36°C; n = 5–6. (C) Effect of 
various perturbations on the magnitude of LTP (normalized EPSC averaged between 21 min 
and 30 min after BS): control, thapsigargin (2 µM), heparin (4 mg ml–1) applied through a 
patch pipette, CPCCOEt (100 µM, αmGluR), BAPTA (30 mM) applied through a patch 
pipette, control at 36°C, dantrolene (30 µM), and Nos1–/–; n = 4–6. **P < 0.001, t-test 
compared with control. 
 
Figure 5  Possible involvement of NICR in ischemic brain damage. (A) Representative 
triphenyltetrazolium chloride (TTC)-stained brain slices 24 h after transient MCAO. (B) 
Infarct volume 24 h after transient MCAO determined using the Leach correction; n = 6 for 
each condition. A two-way ANOVA revealed a significant interaction (P = 0.026), and 
subsequent analyses with Tukey’s multiple comparison test indicated that Nos1+/+ mice 
treated with dantrolene had a significantly smaller infarct volume compared with Nos1–/– 
mice. Data are the mean ± s.e.m. 
 
Figure 6  Involvement of NICR in NO-induced neuronal cell death. (A) NOC12 (500 
µM)-induced intracellular Ca2+ increase in cultured cerebral neurons of Ryr1+/+ (left, n = 30 
cells) or Ryr1–/– (right, n = 28 cells) mice. Ca2+ measurements were made in the absence of 
extracellular Ca2+. (B) NOC12-induced Ca2+ release is blocked by dantrolene (10 µM) at 
35°C. Control, n = 22 cells; dantrolene, n = 21 cells. (C) Neuronal cell death assayed 16 h 
after treatment with 500 µM NOC12 without or with 10 µM dantrolene in cultured cerebral 
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neurons of Ryr1+/+ (left) or Ryr1–/– (right) mice. (D) The extent of cell death was expressed 
as a ratio of the number of propidium iodide-positive cells to that of Hoechst-positive cells. 
Numbers in parentheses (15–22) indicate the number of determinations in each condition 
using different cultures. In each determination >120 cells were analyzed. Data are the mean 
± s.e.m. Statistical significance was determined via an ANOVA followed by a Tukey 
post-hoc test. ***P < 0.0001. 
 






